Garcinol, a natural inhibitor of p300/CBP and PCAF, has anti-tumor effects on several cancer cell lines, including hepatocellular carcinoma, gastric cancer, and triple-negative breast cancer (233). This evidence concerns the gene EP300 and cancer.